查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613393

數位治療市場：按組成部分、按應用分類 - 2025-2030 年全球預測

Digital Therapeutics Market by Component (Devices, Software & Services), Application (Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年數位治療市場估值為64.2億美元，預計到2024年將達到80.5億美元，複合年成長率為26.42%，到2030年將達到331.6億美元。

數位療法 (DTx) 是指由高品質軟體程式提供的實證治療性介入，用於預防、管理和治療身體、心理和行為健康狀況。之所以需要 DTx，是因為它可以與醫療保健系統整合並提供個人化、可擴展的解決方案，從而改善患者的治療結果、降低成本並提高可及性。這些解決方案正在應用於多種疾病，特別是糖尿病、肥胖症、心血管疾病、神經系統疾病等慢性疾病，並在醫院中具有最終用途，數位應用程式可以無縫整合到患者護理工作流程和診所居家照護。影響市場的關鍵成長要素包括慢性病盛行率上升、智慧設備普及率提高、連接性增強以及開始認知到數位療法是可行的治療選擇的支持性法規結構等。 COVID-19 大流行凸顯了對遠距患者參與解決方案的需求，創造了利用遠端醫療協同效應效應的機會，並擴大了服務不足的人群的覆蓋範圍，從而增加了 DTx 的潛力。然而，這個市場面臨著地區報銷結構不同、缺乏標準化以及潛在的監管障礙等限制，為應用帶來了挑戰。人工智慧驅動的個人化治療計劃、具有更廣泛醫療資料系統的整合平台以及增強的用戶參與分析等領域將繼續創新，以推動更好的依從性和結果。企業應專注於與醫療保健提供者、保險公司和科技公司建立策略夥伴關係關係，以利用跨行業的資源和專業知識。投資大規模臨床試驗以證明療效並獲得監管部門的核准對於獲得信任和接受至關重要。 DTx 市場動態的特點是醫療保健、科技和消費性電子產業的交叉，創造了一個需要創新和靈活回應不斷變化的醫療保健需求的動態環境。

主要市場統計
基準年[2023] 64.2億美元
預計年份 [2024] 80.5億美元
預測年份 [2030] 331.6億美元
複合年成長率（%） 26.42%

市場動態：揭示快速發展的數位治療市場的關鍵市場洞察

供應和需求的動態相互作用正在改變數位治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病和與生活方式相關的健康問題增加
    • 政府促進遠端醫療和遠距保健的舉措
    • 與醫療保健應用程式相關的智慧型手機和平板電腦的普及
  • 市場限制因素
    • 新興經濟體對數位療法的認知較低
  • 市場機會
    • 計算和人工智慧在數位治療領域的興起
    • 增加對數位健康業務的資金籌措和投資
  • 市場挑戰
    • 資料隱私和安全問題

波特五力：駕馭數位治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解數位治療市場的外部影響

外部宏觀環境因素在塑造數位治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解數位治療市場的競爭格局

對數位治療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣數位治療市場供應商的績效評估

FPNV定位矩陣是評估數位治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製數位治療市場的成功之路

對於希望加強在全球市場的影響力的公司來說，數位治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和生活方式相關健康問題的發生率增加
      • 政府推動遠端醫療和遠距醫療的舉措
      • 結合醫療保健應用程式部署智慧型手機和平板電腦
    • 抑制因素
      • 新興經濟體對數位療法的認知較低
    • 機會
      • 數位治療中計算與人工智慧的出現
      • 增加對數位健康業務的資金和投資
    • 任務
      • 資料隱私和安全問題
  • 市場區隔分析
    • 組成部分：資料分析軟體和合規服務的重要性日益增加
    • 應用：提高糖尿病和慢性呼吸道疾病數位療法的採用率，需要持續管理和監控
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章數位治療市場：按組成部分

  • 裝置
  • 軟體和服務

第7章數位治療市場：依應用分類

  • 心血管疾病
  • 中樞神經系統疾病
  • 慢性呼吸道疾病
  • 糖尿病
  • 用藥依從性
  • 肌肉骨骼疾病
  • 肥胖
  • 糖尿病前期
  • 禁止抽煙

第8章美洲數位治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太數位治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的數位治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • BehaVR 與 Fern Health 合併成立 RealizedCare，推出數位護理管理平台，釋放數位治療的價值
    • Better Therapeutics 宣布推出 AspyreRxTM 治療成年第 2 型糖尿病患者
    • Lumanity 加入數位治療聯盟
  • 戰略分析和建議

公司名單

  • 2morrow Inc.
  • Akili Interactive Labs, Inc.
  • Ayogo Health Inc.
  • Better Therapeutics, Inc.
  • Big Health, Inc.
  • Biofourmis Inc.
  • Canary Health Technologies Inc.
  • Click Therapeutics, Inc.
  • Cognoa, Inc.
  • DarioHealth Corp.
  • Fern Health, Inc.
  • Fitterfly Healthtech Private Limited
  • Happify, Inc.
  • Headspace Inc.
  • Kaia Health Software Inc.
  • Lark Technologies, Inc.
  • Lumanity Inc.
  • MedRhythms
  • Noom, Inc.
  • Omada Health Inc.
  • Pear Therapeutics, Inc.
  • Propeller Health by ResMed Corp.
  • SilverCloud by American Well Corporation
  • Voluntis by AptarGroup, Inc.
  • Welldoc, Inc.
Product Code: MRR-431752EA4722

The Digital Therapeutics Market was valued at USD 6.42 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 26.42%, to USD 33.16 billion by 2030.

Digital Therapeutics (DTx) refers to evidence-based therapeutic interventions driven by high-quality software programs to prevent, manage, or treat physical, mental, and behavioral health conditions. DTx is necessary due to its ability to integrate with healthcare systems to offer personalized and scalable solutions that contribute to improved patient outcomes, reduced costs, and enhanced accessibility. These solutions have applications across a range of diseases, particularly chronic conditions like diabetes, obesity, cardiovascular diseases, and neurological disorders, and the end-use scope includes hospitals, clinics, and home care settings where digital applications can be seamlessly integrated into patient care workflows. Key growth factors influencing the market include a rising prevalence of chronic diseases, increasing adoption of smart devices, enhanced connectivity, and supportive regulatory frameworks which have begun acknowledging digital therapeutics as viable treatment options. The COVID-19 pandemic highlighted the potential of DTx by underscoring the demand for remote patient engagement solutions, creating opportunities to tap into telehealth synergies, and expanding access to underserved populations. However, the market faces limitations such as varying reimbursement structures, a lack of standardization, and potential regulatory hurdles across different regions, which can pose challenges to widespread adoption. Continued innovations are likely in areas such as AI-driven personalized therapeutic programs, integrative platforms with broader health data systems, and enhanced user engagement analytics that foster better adherence and outcomes. Businesses should focus on forming strategic partnerships with healthcare providers, insurance companies, and technology firms to leverage cross-industry resources and expertise. Investing in extensive clinical trials to demonstrate efficacy and obtaining robust regulatory approvals will be instrumental in gaining trust and acceptance. DTx's market nature, characterized by its intersection with healthcare, technology, and consumer electronics industries, underscores a dynamic environment ripe for innovation and agile responses to evolving healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 6.42 billion
Estimated Year [2024] USD 8.05 billion
Forecast Year [2030] USD 33.16 billion
CAGR (%) 26.42%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Therapeutics Market

The Digital Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of chronic diseases and lifestyle-related health issues
    • Government initiatives promoting telehealth and telemedicine
    • Adoption of smartphones and tablets coupled with healthcare apps
  • Market Restraints
    • Limited awareness regarding digital therapeutics in developing economies
  • Market Opportunities
    • Advent of computing and artificial intelligence in digital therapeutics
    • Rising funding and investments for digital health businesses
  • Market Challenges
    • Issues pertaining to data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the Digital Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Therapeutics Market

A detailed market share analysis in the Digital Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Therapeutics Market

A strategic analysis of the Digital Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 2morrow Inc., Akili Interactive Labs, Inc., Ayogo Health Inc., Better Therapeutics, Inc., Big Health, Inc., Biofourmis Inc., Canary Health Technologies Inc., Click Therapeutics, Inc., Cognoa, Inc., DarioHealth Corp., Fern Health, Inc., Fitterfly Healthtech Private Limited, Happify, Inc., Headspace Inc., Kaia Health Software Inc., Lark Technologies, Inc., Lumanity Inc., MedRhythms, Noom, Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health by ResMed Corp., SilverCloud by American Well Corporation, Voluntis by AptarGroup, Inc., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Devices and Software & Services.
  • Based on Application, market is studied across Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease, Diabetes, Medication Adherence, Musculoskeletal Disorder, Obesity, Prediabetes, and Smoking Cessation.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of chronic diseases and lifestyle-related health issues
      • 5.1.1.2. Government initiatives promoting telehealth and telemedicine
      • 5.1.1.3. Adoption of smartphones and tablets coupled with healthcare apps
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness regarding digital therapeutics in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advent of computing and artificial intelligence in digital therapeutics
      • 5.1.3.2. Rising funding and investments for digital health businesses
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Growing significance of data analysis software and compliance services
    • 5.2.2. Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Therapeutics Market, by Component

  • 6.1. Introduction
  • 6.2. Devices
  • 6.3. Software & Services

7. Digital Therapeutics Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Central Nervous System Disorder
  • 7.4. Chronic Respiratory Disease
  • 7.5. Diabetes
  • 7.6. Medication Adherence
  • 7.7. Musculoskeletal Disorder
  • 7.8. Obesity
  • 7.9. Prediabetes
  • 7.10. Smoking Cessation

8. Americas Digital Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
    • 11.3.2. Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
    • 11.3.3. Lumanity Joins The Digital Therapeutics Alliance
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 2morrow Inc.
  • 2. Akili Interactive Labs, Inc.
  • 3. Ayogo Health Inc.
  • 4. Better Therapeutics, Inc.
  • 5. Big Health, Inc.
  • 6. Biofourmis Inc.
  • 7. Canary Health Technologies Inc.
  • 8. Click Therapeutics, Inc.
  • 9. Cognoa, Inc.
  • 10. DarioHealth Corp.
  • 11. Fern Health, Inc.
  • 12. Fitterfly Healthtech Private Limited
  • 13. Happify, Inc.
  • 14. Headspace Inc.
  • 15. Kaia Health Software Inc.
  • 16. Lark Technologies, Inc.
  • 17. Lumanity Inc.
  • 18. MedRhythms
  • 19. Noom, Inc.
  • 20. Omada Health Inc.
  • 21. Pear Therapeutics, Inc.
  • 22. Propeller Health by ResMed Corp.
  • 23. SilverCloud by American Well Corporation
  • 24. Voluntis by AptarGroup, Inc.
  • 25. Welldoc, Inc.

LIST OF FIGURES

  • FIGURE 1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023